Stock MBIO MINDBIO THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials MindBio Therapeutics Corp.

Equities

MBIO

CA60256C1086

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 09:30:00 2024-05-31 am EDT 		5-day change 1st Jan Change
0.05 CAD +11.11% Intraday chart for MindBio Therapeutics Corp. -.--% +100.00%
May. 13 MindBio Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
May. 02 Mindbio Therapeutics Corp. Announces Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3 CI

Valuation

Fiscal Period: June 2023
Capitalization 1 -
Enterprise Value (EV) 1 -
P/E ratio -2.04 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF -
FCF Yield -
Price to Book -1.97 x
Nbr of stocks (in thousands) -
Reference price 2 0.0794
Announcement Date 11/2/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2022 2023
Net sales - -
EBITDA 1 -5.361 -
EBIT 1 -5.4 -3.22
Operating Margin - -
Earnings before Tax (EBT) 1 -7.475 -4.287
Net income 1 -7.475 -4.287
Net margin - -
EPS 2 -0.1399 -0.0389
Free Cash Flow - -1.395
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 11/2/23 11/2/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2022 2023
Net Debt 1 3.15 4.64
Net Cash position 1 - -
Leverage (Debt/EBITDA) -0.5873 x -
Free Cash Flow - -1.39
ROE (net income / shareholders' equity) - 88.9%
ROA (Net income/ Total Assets) - -176%
Assets 1 - 2.437
Book Value Per Share 2 -0.0800 -0.0400
Cash Flow per Share 2 0.0200 0
Capex - -
Capex / Sales - -
Announcement Date 11/2/23 11/2/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
MINDBIO THERAPEUTICS CORP. Stock MindBio Therapeutics Corp.
+100.00% 4.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MBIO Stock
  4. Financials MindBio Therapeutics Corp.